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OBJECTIVES The study compared the influence of sympathetic stimulation on transmural and spatial
dispersion of repolarization between LQT1 and LQT2 forms of congenital long QT
syndrome (LQTS).
BACKGROUND Cardiac events are more associated with sympathetic stimulation in LQT1 than in LQT2 or
LQT3 syndrome. Experimental studies have suggested that the interval between Tpeak and
Tend (Tp-e) in the electrocardiogram (ECG) reflects transmural dispersion of repolarization
across the ventricular wall.
METHODS We recorded 87-lead body-surface ECGs before and after epinephrine infusion (0.1
mg/kg/min) in 13 LQT1, 6 LQT2, and 7 control patients. The Q-Tend (QT-e), Q-Tpeak
(QT-p), and Tp-e were measured automatically from 87-lead ECGs, corrected by Bazett’s
method (QTc-e, QTc-p, Tcp-e), and averaged among all 87-leads and among 24-leads,
which reflect the potential from the left ventricular free wall. As an index of spatial dispersion
of repolarization, the dispersion of QTc-e (QTc-eD) and QTc-p (QTc-pD) were obtained
among 87-leads and among 24-leads, and were defined as the interval between the maximum
and the minimum of the QTc-e and the QTc-p, respectively.
RESULTS Epinephrine significantly increased the mean QTc-e but not the mean QTc-p, resulting in
a significant increase in the mean Tcp-e in both LQT1 and LQT2, but not in control
patients. The epinephrine-induced increases in the mean QTc-e and Tcp-e were larger in
LQT1 than in LQT2, and were more pronounced when the averaged data were obtained
from 24-leads than from 87-leads. Epinephrine increased the maximum QTc-e but not the
minimum QTc-e, producing a significant increase in the QTc-eD in both LQT1 and LQT2
patients, but not in control patients. The increase in the QTc-eD was larger in LQT1 than
in LQT2 patients.
CONCLUSIONS Our data suggest that sympathetic stimulation produces a greater increase in both transmural
and spatial dispersion of repolarization in LQT1 than in LQT2 syndrome, and this may
explain why LQT1 patients are more sensitive to sympathetic stimulation. (J Am Coll
Cardiol 2001;37:911–9) © 2001 by the American College of Cardiology
The congenital long QT syndrome (LQTS) is a hereditary
disorder associated with prolonged ventricular repolariza-
tion (QT interval) and life-threatening polymorphic ven-
tricular tachycardia, torsade de pointes (TdP) (1–5). Recent
genetic studies have shown that congenital LQTS is a
primary electrical disease caused by mutation in specific ion
channel genes (6–8). Mutations in KCNQ1 and KCNE1
are responsible for defects in the slowly activating compo-
nent of the delayed rectifier potassium current (IKs) that
underlies the LQT1 and LQT5 forms of the LQTS,
whereas mutations in HERG and KCNE2 are responsible
for defects in the rapidly activating component of the
delayed rectifier potassium current (IKr) responsible for
LQT2 and LQT6. Mutations in SCN5A alter the function
of the sodium channel (INa) responsible for LQT3.
Sympathetic stimulation has long been appreciated to
play a pivotal role in the genesis of QT prolongation and
TdP in some forms of congenital LQTS (4). Among the
LQT1, LQT2, and LQT3 forms of LQTS, cardiac events
are more likely to be associated with sympathetic stimula-
tion (physical or emotional stress) in the LQT1 than in
either LQT2 or LQT3 syndrome. Exercise-related events
seem to dominate the clinical picture in LQT1 (9). In
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contrast, a sudden startle in the form of an auditory stimulus
(alarm clock) is the predominant trigger of cardiac events in
LQT2 (10), whereas cardiac events usually occur at rest or
during sleep in LQT3 (9).
Spatial heterogeneity of repolarization represented by QT
dispersion has been proposed as a marker of electrical
instability under several conditions, including LQTS (11–
13). Conversely, a growing number of studies have focused
on transmural heterogeneity of repolarization across the
ventricular wall (epicardial, mid-myocardial (M), and endo-
cardial cells) and have suggested that an amplified transmu-
ral dispersion of repolarization (TDR) was linked to ven-
tricular arrhythmias such as TdP under long QT conditions
(14–24). Recent experimental studies using arterially per-
fused canine left ventricular wedge have suggested that both
the peak and the end of the T wave in the electrocardiogram
(ECG) are coincident with repolarization of epicardial and
maximal M-cell action potentials, respectively, so that the
interval between the Tpeak and Tend (Tp-e) reflects TDR
(16–21).
In the present study, we recorded 87-lead body-surface
mapping before and after infusion of epinephrine, an
alpha 1 beta-adrenergic agonist, in patients with LQT1
and LQT2 syndrome, to compare the influence of sympa-
thetic stimulation on both transmural and spatial dispersion
of repolarization between LQT1 and LQT2 syndrome.
METHODS
Patient population. The study population included 13
patients afflicted with LQT1 syndrome (KCNQ1 mutation,
7 unrelated families), 6 patients with LQT2 syndrome
(HERG mutation, 3 unrelated families) and 7 healthy
volunteers as a control group. Seven LQT1 families had
seven discrete missense mutations, and three LQT2 families
had three discrete mutations. The LQT1 group consisted of
10 females and 3 males, ranging in age from 6 to 54 years
(mean, 25 6 17 years). The LQT2 group included 5
females and 1 male, ranging in age from 19 to 60 years
(mean, 31 6 16 years). The control group included 4
females and 3 males, ranging in age from 13 to 51 years old
(mean, 30 6 12 years).
87-lead body-surface mapping. All protocols were re-
viewed and approved by our Ethical Review Committee,
and informed consent was obtained from all patients. All
antiarrhythmic medications were discontinued for at least
five drug half-lives. Body-surface potential mapping was
recorded with a VCM-3000 (Fukuda Denshi, Tokyo, Ja-
pan) (25). Eighty-seven body-surface leads were arranged in
a lattice-like pattern (13 3 7 matrix), except for four leads
on the midaxillary lines, which covered the entire thoracic
surface; 59 leads were located on the anterior chest (rows
A–I) and 28 leads on the back (rows J–M). These 87
unipolar ECGs with Wilson’s central terminal as a refer-
ence, the standard 12-lead ECG, and the Frank X, Y, and
Z scalar leads were simultaneously recorded during sinus
rhythm. All subjects remained relaxed in the supine position
during recording. These ECG data were scanned with
multiplexers and digitized using analog-digital converters
with a sampling rate of 1,000 samples/second/channel. The
digitized data were stored on a floppy disk and transferred to
a personal computer (PC-9821 Xv13, NEC, Tokyo, Japan)
with the analysis program developed by our institution.
Measurements. Eighty-seven-lead body-surface ECGs
were analyzed using a semiautomated digitizing program.
The Q-Tend interval (QT-e) was defined as the time
interval between the QRS onset and the point at which the
isoelectric line intersected a tangenital line drawn at the
maximal downslope of the positive T-wave or at the
maximal upslope of the negative T-wave. The Q-Tpeak
interval (QT-p) was defined as the time interval between the
QRS onset and the point at the peak of the positive T-wave
or the nadir of the negative T-wave. When the T-wave had
a biphasic or a notched configuration, the peak of the T-
wave was defined as that of the dominant T-wave. The
QT-e, the QT-p, and the Tp-e (QT-e minus QT-p) as an
index of TDR were measured automatically from all 87-lead
ECGs, corrected to heart rate by Bazett’s method (QTc-e
[corrected Q-Tend interval] QTc-p [corrected Q-Tpeak
interval] Tcp-e:
QT-e/˛ RR, QT-p/˛ RR, Tp-e/˛ RR),
and averaged among all 87-leads and among 24-leads (rows
G–K, columns 2–6), which are thought to reflect the
potential from the left ventricular free wall. The Tcp-e/
QTc-e ratio was also calculated. Each point determined by
the computer was checked visually and edited manually for
each lead. The maximum (max) and the minimum (min) of
the QTc-e and the QTc-p were also obtained from all
87-leads and among 24-leads. As an index of spatial
dispersion of repolarization, dispersion of the QTc-e (QTc-
eD) and dispersion of the QTc-p (QTc-pD) were obtained
from 87-leads and from 24-leads, and were defined as the
interval between the max and the min of the QTc-e and the
QTc-p, respectively.
Epinephrine administration. Epinephrine (0.1 mg/kg), an
alpha 1 beta-adrenergic agonist, was injected and was
followed by continuous infusion at a constant rate of
Abbreviations and Acronyms
APD 5 action potential duration
ECG 5 electrocardiogram
LQTS 5 long QT syndrome
QTc-e 5 corrected Q-Tend interval
QTc-p 5 corrected Q-Tpeak interval
QTc-eD 5 dispersion of QTc-e
QTc-pD 5 dispersion of QTc-p
QT-e 5 Q-Tend interval
Tcp-e 5 corrected interval between Tpeak and Tend
TdP 5 torsade de pointes
TDR 5 transmural dispersion of repolarization
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0.1 mg/kg/min in all group patients. Body-surface mapping
was recorded during sinus rhythm under baseline conditions
and at steady-state conditions of catecholamine (3 to 5 min
after epinephrine infusion), in which both the RR and QT
intervals reached steady state.
Statistical analysis. Data are reported as the mean 6 SD.
Two-way repeated-measures ANOVA followed by the
Scheffe´ test was used to compare measurements made before
and after epinephrine administration, and to compare each
parameter among LQT1, LQT2, and control patients.
Differences of each parameter before and after epinephrine
were compared among the three groups by using one-way
ANOVA followed by the Scheffe´ test. A value of p , 0.05
was regarded as significant.
RESULTS
There were no significant differences in the heart rate
among the three groups both before and after epinephrine
(before epinephrine: LQT1, 64 6 7/min; LQT2, 56 6
12/min; control, 65 6 9/min; after epinephrine: LQT1,
75 6 7/min; LQT2, 63 6 9/min; control, 73 6 9/min).
Influence of epinephrine on TDR. Figure 1 illustrates
24-lead ECGs (G–K: 2–6), which are expected to reflect
the potential from the left ventricular free wall before and
after epinephrine in a patient with LQT1 syndrome. A
representative ECG (H4 in this case) is shown on the upper
trace in each panel. The ECGs showed broad-based T-
waves commonly observed in LQT1 patients. Both the
QTc-e and the QTc-p were prolonged (603, 482 ms1/2) and
the Tcp-e was increased (121 ms1/2) under the baseline
condition. Epinephrine produced a prominent prolongation
in the QTc-e (712 ms1/2), but a mild prolongation in the
QTc-p (520 ms1/2), resulting in a dramatic increase in the
Tcp-e (192 ms1/2). Figure 2 illustrates 24-lead ECGs before
and after epinephrine in a patient with LQT2 syndrome. A
representative ECG (I4 in this case) is shown on the upper
trace in each panel, depicting low-amplitude T wave with
notched appearance commonly seen in LQT2 syndrome. As
in the LQT1 patient, the QTc-e and the QTc-p were
prolonged (518, 414 ms1/2) and the Tcp-e was increased
(104 ms1/2) under the baseline condition. Epinephrine
produced a moderate prolongation in the QTc-e (618
ms1/2) and the QTc-p (494 ms1/2), resulting in a mild
increase in the Tcp-e (124 ms1/2). Figure 3 illustrates
24-lead ECGs before and after epinephrine in a control
patient. A representative ECG (H4 in this case) is shown on
Figure 1. Twenty-four-lead ECGs (G–K: 2–6) that are expected to reflect the potential from the left ventricular free wall under baseline condition (A) and
during epinephrine infusion (B) in a patient (pt) with LQT1 syndrome. A representative ECG (H4) is shown on the upper trace in each panel. The ECGs
showed broad-based T waves commonly observed in LQT1 patients. Both the QTc-e and QTc-p were prolonged (603, 482 ms1/2) and the Tcp-e was
increased (121 ms1/2) under the baseline condition (A). Epinephrine produced a prominent prolongation in the QTc-e (712 ms1/2), but a mild prolongation
in the QTc-p (520 ms1/2), resulting in a dramatic increase in the Tcp-e (192 ms1/2) (B).
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the upper trace in each panel. The QTc-e and the QTc-p
were much shorter (396, 314 ms1/2) and the Tcp-e was
smaller (82 ms1/2) than those in the LQT1 and LQT2
patients under the baseline condition. Epinephrine pro-
duced no significant changes in the QTc-e (410 ms1/2), the
QTc-p (325 ms1/2), and the Tcp-e (85 ms1/2).
Changes in the mean QTc-e, QTc-p, Tcp-e, and Tcp-
e/QTc-e ratio, which were averaged among 87-lead ECG
before and after epinephrine administration, are summa-
rized in Table 1. The mean QTc-e, QTc-p, Tcp-e, and
Tcp-e/QTc-e ratios before epinephrine were larger in
LQT1 and LQT2 patients than in control patients (p ,
0.05). There were no significant differences in these baseline
parameters between LQT1 and LQT2 patients. Figure 4
shows composite data of the differences before and after
epinephrine in the mean QTc-e, QTc-p, Tcp-e, and Tcp-
e/QTc-e ratios, which were averaged among 87-leads, in
LQT1, LQT2, and control patients. The changes in the
mean QTc-e with epinephrine were largest in LQT1
patients, intermediate in LQT2 patients, and were not
significant in control patients, whereas changes in the mean
QTc-p were not different among the three groups. As a
consequence, changes in the Tcp-e and the Tcp-e/QTc-e
ratios were largest in LQT1 patients, intermediate in
LQT2 patients, and were not significant in control
patients. When the same parameters were averaged
among 24-leads, reflecting the potential from the left
ventricular wall, the changes in the mean QTc-e, Tcp-e,
and Tcp-e/QTc-e ratio in LQT1 and LQT2 patients
were more pronounced than those that were averaged
among all 87-leads.
Influence of epinephrine on spatial dispersion of repo-
larization. Changes in the max QTc-e, min QTc-e, QTc-
eD, max QTc-p, min QTc-p, and QTc-pD, which were
obtained from 87-lead ECGs, before and after epinephrine
administration, are summarized in Table 2. All parameters
except QTc-pD before epinephrine were larger in LQT1
and LQT2 patients than in control patients (p , 0.05).
There were no significant differences in these baseline
parameters between LQT1 and LQT2 patients. Figure 5
shows composite data of the differences before and after
epinephrine in the max QTc-e, min QTc-e, QTc-eD, max
QTc-p, min QTc-p, and QTc-pD, which were obtained
from 87-leads in LQT1, LQT2, and control patients. The
changes in the max QTc-e with epinephrine were largest in
Figure 2. Twenty-four-lead ECGs (G–K: 2–6) under baseline condition (A) and during epinephrine infusion (B) in a patient (pt) with LQT2 syndrome.
A representative ECG (I4) is shown on the upper trace in each panel. The ECGs showed low-amplitude T wave with a notched appearance commonly
seen in LQT2 patients. The QTc-e and QTc-p were prolonged (518, 414 ms1/2) and the Tcp-e was increased (104 ms1/2) under the baseline condition
(A). Epinephrine produced a moderate prolongation in the QTc-e (618 ms1/2) and the QTc-p (494 ms1/2), resulting in a mild increase in the Tcp-e (124
ms1/2) (B).
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LQT1 patients, intermediate in LQT2 patients, and were
not significant in control patients, whereas changes in the
min QTc-e were not different between LQT1 and LQT2
patients, but significantly larger than those in control
patients. As a consequence, the changes in the QTc-eD
were larger in LQT1 patients than those in LQT2 and
control patients. Conversely, no significant differences
were seen in the changes in the max QTc-p, min QTc-p,
and QTc-pD among the three groups. When the same
parameters were obtained from 24-leads, reflecting the
potential from the left ventricular wall, changes in the
parameters were similar to those obtained from all
87-leads.
DISCUSSION
Transmural and spatial dispersion of repolarization in
LQT1 and LQT2 syndrome. The congenital LQTS is
characterized by a prolonged QT interval and TdP, which
often cause severe symptoms such as syncope or sudden
cardiac death (1–5). In addition to prolonged QT interval,
QT dispersion, measured as interlead variability of the QT
Figure 3. Twenty-four-lead ECGs (G–K: 2–6) under baseline condition (A) and during epinephrine infusion (B) in a control patient (pt). A representative
ECG (H4) is shown on the upper trace in each panel. The QTc-e and QTc-p were much shorter (396, 314 ms1/2) and the Tcp-e was smaller (82 ms1/2)
than those in LQT1 and LQT2 patients under the baseline condition (A). Epinephrine produced no significant changes in the QTc-e (410 ms1/2), the
QTc-p (325 ms1/2), and the Tcp-e (85 ms1/2).
Table 1. Epinephrine-Induced Changes in the Mean QTc-e, the Mean QTc-p, the Mean Tcp-e, and the Mean Tcp-e/QTc-e Ratio,
Which Are Averaged Among All 87-Leads, in LQT1, LQT2, and Control Patients
Mean QTc-e Mean QTc-p Mean Tcp-e Mean Tcp-e/QTc-e ratio
Before After Before After Before After Before After
LQT1 pts
(n 5 13)
543 6 64‡ 618 6 63*† 406 6 49‡ 419 6 48‡ 136 6 29‡ 198 6 33*† 0.25 6 0.04‡ 0.32 6 0.04*†
LQT2 pts
(n 5 6)
532 6 33‡ 580 6 24*‡ 400 6 16‡ 406 6 18‡ 131 6 21‡ 173 6 13*‡ 0.25 6 0.03‡ 0.30 6 0.2*‡
Control pts
(n 5 7)
400 6 19 397 6 18 321 6 19 314 6 15 78 6 7 82 6 6 0.19 6 0.02 0.20 6 0.01
*p , 0.05 vs. before. †p , 0.05 vs. LQT2 pts. p , 0.005 vs. Control pts. ‡p , 0.05 vs. Control pts.
pts 5 patients; QTc-e 5 corrected Q-Tend interval; QTc-p 5 corrected Q-Tpeak interval; Tpc-e 5 corrected Tpeak-Tend interval.
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interval, is believed to be a marker of spatially heterogeneous
ventricular repolarization and electrical instability. Al-
though several clinical studies have reported an increased
QT dispersion in the congenital LQTS (11–13), recent
experimental studies have suggested an important role of
transmural electrical heterogeneity—that is, TDR across the
ventricular wall in the generation of TdP under long QT
conditions (15–24). Experimental studies have suggested
that the Tp-e in each ECG lead serves as an index of TDR
across the ventricle of which the ECG lead reflects the
potential (16–21). In contrast, the QT dispersion is thought
to provide an index of interventricular differences in the
repolarization of M regions throughout the ventricle (spatial
dispersion of repolarization) (26).
Under the baseline condition in the present study, the
max QTc-e, min QTc-e, QTc-eD, max QTc-p, min
QTc-p, and QTc-pD were larger in LQT1 and LQT2
patients than in control patients, consistent with previous
clinical studies (11–13). It is noteworthy that both QTc-eD
and QTc-pD were comparable between LQT1 and LQT2
patients in the setting of similar values of the QTc-e and the
QTc-p in our study population. To our best knowledge, our
study is the first one to compare the QTc-eD and QTc-pD
between LQT1 and LQT2 syndrome. With regard to
TDR, the Tcp-e as well as Tcp-e/QTc-e ratio were larger in
LQT1 and LQT2 patients than in control patients. Once
again, no significant differences existed in the Tcp-e be-
tween LQT1 and LQT2 patients. These data suggest that
both transmural and spatial dispersion of repolarization are
increased in patients with congenital LQTS, but that no
significant differences were observed between LQT1 and
LQT2 syndrome under baseline conditions without strong
sympathetic stimulation.
Influence of sympathetic stimulation on transmural and
spatial dispersion of repolarization in LQT1 and LQT2
syndrome. Physical exercise and strong emotion are known
to precipitate syncope and sudden cardiac death in patients
with congenital LQTS (3–5). Several experimental models
of LQTS (27) and clinical studies (4,28) have suggested that
catechoalmine-enhanced early after depolarizations and
triggered activity both play a pivotal role in the genesis of
QT prolongation and TdP. However, conditions that give
rise to early after depolarizations and triggered activity also
produce a marked dispersion of ventricular repolarization in
this syndrome (5).
Among three forms of congenital LQTS, the LQT1
syndrome is reported clinically as well as experimentally to
be more sensitive to sympathetic stimulation and more
responsive to beta-blockers than either LQT2 or LQT3
syndrome (9,17,20). Sympathetic (beta-adrenergic) stimu-
Figure 4. Comparison of the differences before and after epinephrine in the mean QTc-e (A), QTc-p (B), Tcp-e (C), and Tcp-e/QTc-e ratio (D), which
were averaged among 87-leads, in LQT1, LQT2, and control groups. The changes in the mean QTc-e with epinephrine were largest in LQT1 patients,
intermediate in LQT2 patients, and were not significant in control patients (A), whereas changes in the mean QTc-p were not different among the three
groups (B). As a consequence, the changes in the Tcp-e (C) and Tcp-e/QTc-e ratio (D) were largest in LQT1 patients, intermediate in LQT2 patients,
and were not significant in control patients.
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lation is known to augment a number of currents, including
Ca21-activated IKs, Ca
21-activated chloride current
(ICl(Ca)), and Na
1/Ca21 exchange current (INa-Ca). An
increase in net outward repolarizing current, due to a
relatively large increase of IKs and ICl(Ca) versus INa-Ca, is
thought to be responsible for the abbreviation of action
potential duration (APD) and QT interval in response to
beta-adrenergic stimulation under normal conditions (5). A
defect in IKs (especially in the M region) could offset this
balance and account for failure of beta-adrenergic stimula-
tion to abbreviate APD and QT interval in LQT1 syn-
drome (17). A recent experimental study by Shimizu and
Antzelevitch (20) has elucidated the cellular basis for dif-
ferential effects of beta-adrenergic stimulation in the LQT1,
LQT2, and LQT3 models of the congenital LQTS. In the
LQT1 model produced by an IKs blocker, chromanol 293B,
beta-adrenergic stimulation with isoproterenol has been
shown to prolong the QT interval and the APD of the M
cell in which IKs is intrinsically small, but to abbreviate that
of the epicardial and the endocardial cells, resulting in a
persistent increase in TDR and in a widening of the T wave,
as commonly seen in LQT1 patients (29). In contrast,
isoproterenol initially prolonged and then abbreviated the
QT interval and the APD of the M cell just above the
control level, whereas the APD of the epicardial and the
endocardial cells was constantly abbreviated, resulting in a
transient increase in TDR. In the clinic, Sun and co-
workers (30) recently reported that epinephrine markedly
increased the QT-eD (dispersion of Q-Tend interval) as an
index of spatial dispersion of repolarization in patients with
LQTS. Commensurate with this, Priori et al. (13) have
shown that the QT-eD was significantly reduced by left
cardiac sympathetic denervation in LQTS patients who did
not respond to beta-blockers.
In the present study, epinephrine increased the Tcp-e as
an index of TDR in LQT1 patients much more than that in
LQT2 patients; both were more pronounced than that in
control patients. This was mainly due to much more
prolongation of the mean QTc-e than that of the mean
QTc-p in LQT1 patients, and was very compatible with the
experimental data by Shimizu et al. (17,20). Our result
showing significant increase in the QTc-eD with epineph-
rine in both LQT1 and LQT2 patients is consistent with
the findings by Sun et al. (30). Furthermore, the changes in
the QTc-eD with epinephrine in LQT1 patients were larger
than those in LQT2 patients. These data suggest that
strong sympathetic stimulation produces a greater increase
in both transmural and spatial dispersion of repolarization in
LQT1 than in LQT2 patients, and this may support the
fact that LQT1 patients are much more at risk under strong
sympathetic stimulation.
Comparison between 87-lead and 24-lead body-surface
mapping recordings. The mean Tcp-e before and after
epinephrine averaged among 24-leads, which are thought to
reflect the potential from the left ventricular free wall, was
greater than that averaged among all 87-leads in bothTa
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LQT1 and LQT2 patients. In addition, the QTc-eD,
which was defined as the difference between the max QTc-e
and the min QTc-e, was comparable, when it was calculated
from 24-leads and from 87-leads. Difficulties of the mea-
surement of QT dispersion at the body surface are well-
known problems of body-surface mapping, including the
effects of distance from the heart and a summation of
currents from various regions at any electrical site. For all
that, our data indicate that both transmural and spatial
dispersion of repolarization in the left ventricular free wall
and probably ventricular septum are more pronounced, and
this may be more important in the arrhythmogeneity in
patients with LQT1 and LQT2 syndrome.
Conclusions. The present data suggest that sympathetic
stimulation produces a significant increase in both transmu-
ral and spatial dispersion of repolarization in LQT1 and
LQT2 syndrome but not in control patients. Moreover, the
increase in the transmural and spatial dispersion of repolar-
ization with epinephrine is greater in LQT1 than in LQT2
syndrome, providing further support of the fact why LQT1
patients are more sensitive to sympathetic stimulation.
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